Harold:
There is, to my knowledge, no link. And that was pretty much the summary of the CD40L part. If I have time later today, I'll comment on the remainder of the article.
BTRN languishing? It's orphaned, first, no *expected* news until the phase I results for allomune, phase II for 507 or partnering of allo, none of which is thought to be imminent, second, and tax selling, third. There may be a fourth...... perhaps some don't expect positive results, but I'm not aware of any reason for a bias.
Rick |
